4
Changes in Ownership
Sionna Therapeutics, Inc. Filed Acc 0001451612-25-000006
Director sold 49,546 shares at an average $29.99 ($1,485,790)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Booth Bruce · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-10-03 | Sale : show line 1 in the form 10b5-1 | −31,198 | $30.00 | $935,940 | 2,790,054 | I |
| 2025-10-03 | Sale : show line 2 in the form 10b5-1 | −6,548 | $30.00 | $196,440 | 787,527 | I |
| 2025-10-06 | Sale : show line 3 in the form 10b5-1 | −9,753 | $29.95 | $292,102 | 2,780,301 | I |
| 2025-10-06 | Sale : show line 4 in the form 10b5-1 | −2,047 | $29.95 | $61,308 | 785,480 | I |
| Open-market sales · 49,546 sh · avg $29.99 · $1,485,790 | ||||||
Loading xslF345X05/form4-10072025_091026.xml…